SEC Tracker
Get the app

Passage BIO PASG

OrbiMed Private Investments VII (Stockholder) plans to sell 2,985,518 PASG shares, about $2.7M

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Dec 4, 2024
  2. Broker: Themis Trading LLC
  3. Shares acquired by: IPO

All of OrbiMed Private Investments VII's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 230,321 shares at $0.6 on Dec 20, 2024 · Form 4
  • Sold 19,481 shares at $0.77 on Jan 6, 2025 · Form 4
  • Sold 52,536 shares at $0.71 on Jan 7, 2025 · Form 4
  • Sold 75,007 shares at $0.68 on Jan 8, 2025 · Form 4
  • Sold 126,209 shares at $0.66 on Jan 10, 2025 · Form 4
  • Sold 17,986 shares at $0.64 on Jan 13, 2025 · Form 4
  • Sold 79,024 shares at $0.6 on Jan 14, 2025 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Passage BIO files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Pulmatrix PULM public float $25M, Jun 30, 2025
  2. Scynexis SCYX public float $26M, Jun 30, 2025
  3. Palatin Technologies PTN public float $26M, Dec 31, 2025
  4. Curis CRIS public float $25M, Jun 30, 2025
  5. Kala Bio KALA public float $25M, Jun 30, 2025